Topic
Polymyalgia rheumatica and giant cell arteritis
💡 What You Need to Know
- Polymyalgia Rheumatica (PMR): An inflammatory disorder causing widespread muscle pain and stiffness, primarily affecting the shoulders, neck, and hip girdles. It is more common in individuals over 50 years old.
- Giant Cell Arteritis (GCA): Also known as temporal arteritis, GCA is a serious systemic vasculitis affecting medium and large arteries, most commonly the temporal arteries. It is considered a medical emergency due to the risk of permanent vision loss.
- Strong Association: PMR and GCA frequently coexist. Approximately 15-20% of PMR patients develop GCA, and about 50% of GCA patients also experience PMR symptoms.
- Urgent Recognition: Prompt diagnosis and aggressive treatment of GCA are crucial to prevent severe complications, especially irreversible blindness.
🤒 Associated Symptoms
- PMR Symptoms:
- Bilateral Pain and Stiffness: Predominantly in the shoulders, neck, and hip girdles.
- Morning Stiffness: Typically lasting more than 45 minutes, often severe enough to impair daily activities.
- Constitutional Symptoms: Fatigue, low-grade fever, malaise, and unintentional weight loss.
- Limited Range of Motion: Due to pain and stiffness in affected joints.
- GCA Symptoms:
- New-Onset Headache: Often severe, localized to the temporal region, throbbing, or persistent.
- Scalp Tenderness: Pain or sensitivity when touching the scalp or combing hair.
- Jaw Claudication: Pain or fatigue in the jaw muscles when chewing, which resolves with rest.
- Visual Disturbances: Transient vision loss (amaurosis fugax), double vision (diplopia), or sudden, permanent vision loss in one or both eyes. This is a medical emergency.
- Arm Claudication: Pain or fatigue in the arms with activity, due to vasculitis in subclavian or axillary arteries.
- Constitutional Symptoms: Fever, night sweats, fatigue, and significant weight loss.
🛡 Crucial Precautions
- Immediate GCA Evaluation: Any new headache, visual changes, jaw pain, or scalp tenderness in a patient with PMR or suspected GCA warrants urgent medical assessment and immediate initiation of high-dose corticosteroids.
- Corticosteroid Side Effect Monitoring: Patients on long-term corticosteroids must be monitored for potential side effects including osteoporosis, diabetes mellitus, hypertension, cataracts, glaucoma, and increased infection risk.
- Bone Health Prophylaxis: Implement strategies to prevent corticosteroid-induced osteoporosis, such as calcium and vitamin D supplementation, and consider bisphosphonates as appropriate.
- Infection Awareness: Advise patients on immunosuppressive therapies (e.g., methotrexate, tocilizumab) to report any signs of infection (fever, chills, unusual fatigue) promptly.
- Vaccination Status: Ensure patients are up-to-date on recommended vaccinations, especially influenza, pneumococcal, and zoster vaccines, considering their immunosuppressed state.
🍽 Dietary Directions & Restrictions
- Calcium and Vitamin D Intake: Crucial for bone health to counteract the osteoporotic effects of long-term corticosteroid therapy. Encourage dairy products, fortified foods, and leafy greens.
- Sodium Restriction: To help manage fluid retention and hypertension, common side effects of corticosteroids. Limit processed foods and added salt.
- Blood Glucose Management: Monitor carbohydrate intake and choose complex carbohydrates to help manage potential steroid-induced hyperglycemia.
- Potassium-Rich Foods: To help replenish potassium levels, which can be depleted by corticosteroids. Include bananas, oranges, spinach, and potatoes.
- Adequate Hydration: Maintain good fluid intake, especially if experiencing fever or constitutional symptoms.
⚠️ Attendant Guidelines
- Emergency Protocol: Instruct patients to seek immediate medical attention (emergency department or urgent rheumatology consultation) for any sudden visual changes, severe new headache, or jaw pain.
- Medication Adherence: Emphasize strict adherence to prescribed corticosteroid regimens and other immunosuppressants. Patients must never abruptly discontinue corticosteroids due to the risk of adrenal crisis and disease flare.
- Regular Follow-up: Stress the importance of consistent follow-up appointments with a rheumatologist for disease activity monitoring, medication adjustments, and management of side effects.
- Symptom Reporting: Encourage patients to report any new or worsening symptoms, particularly those suggestive of GCA, or any unusual side effects from medications.
- Activity Modification: Advise on activity modification during flares to manage pain and stiffness, while encouraging gentle movement to prevent deconditioning.
🩺 Physician's Perspective
- Prompt Diagnosis of GCA: Clinical suspicion of GCA necessitates immediate initiation of high-dose corticosteroids (e.g., prednisone 40-60 mg/day or IV methylprednisolone for visual symptoms) to prevent irreversible vision loss, even before confirmatory tests.
- Temporal Artery Biopsy (TAB): While imaging is evolving, TAB remains the gold standard for GCA diagnosis, ideally performed within 7-14 days of starting steroids.
- Differential Diagnosis: Carefully differentiate PMR from other conditions presenting with similar musculoskeletal pain, such as rheumatoid arthritis, osteoarthritis, hypothyroidism, and paraneoplastic syndromes.
- Corticosteroid Tapering: Develop a slow, individualized corticosteroid tapering schedule based on clinical response and inflammatory markers to minimize side effects and prevent disease relapse.
- Steroid-Sparing Agents: Consider adjunctive therapies like methotrexate or tocilizumab (an IL-6 receptor antagonist) for patients with GCA who require high-dose or prolonged corticosteroids, or those who relapse during tapering.
🎓 Academic & Nursing Corner
- Patient Education on Medications: Educate patients thoroughly on corticosteroid dosing, potential side effects, the importance of not stopping abruptly, and the role of steroid-sparing agents.
- Pain Assessment and Management: Regularly assess pain levels and stiffness, implementing pharmacological and non-pharmacological interventions to improve patient comfort and function.
- Functional Status Monitoring: Evaluate the patient's ability to perform activities of daily living (ADLs) and instrumental ADLs (IADLs), providing referrals to occupational or physical therapy as needed.
- Monitoring for Complications: Vigilantly monitor vital signs, blood glucose, blood pressure, and signs of infection or gastrointestinal bleeding, especially in patients on high-dose corticosteroids.
- Emotional Support: Provide empathetic support and resources for coping with chronic pain, fatigue, and the psychological impact of long-term steroid use.
🔬 Clinical Reference Index
- Inflammatory Markers: Elevated Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) are characteristic, though normal levels do not exclude GCA.
- Temporal Artery Biopsy (TAB): Histopathological findings in GCA include transmural inflammation, giant cells, and disruption of the internal elastic lamina. Skip lesions can occur, necessitating longer biopsy segments.
- Imaging Modalities for GCA:
- High-Resolution Ultrasound: Can detect the 'halo sign' (hypoechoic wall thickening) in temporal arteries.
- Magnetic Resonance Angiography (MRA) / Computed Tomography Angiography (CTA): Useful for detecting large vessel involvement.
- Positron Emission Tomography (PET) Scan: Can identify inflammation in large vessels, particularly in atypical GCA presentations.
- Treatment Guidelines:
- PMR: Typically low-to-moderate dose oral corticosteroids (e.g., prednisone 15-20 mg/day).
- GCA: High-dose oral prednisone (e.g., 40-60 mg/day) or intravenous methylprednisolone (e.g., 250-1000 mg/day for 3 days) for visual symptoms.
- ACR/EULAR Classification Criteria: Used for the classification of PMR and GCA in research and clinical practice.